- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05728762
Light Emitting Diodes With a Continuous Spectrum of 430-780nm for Myopia Prevention
Effect of Light Emitting Diodes With a Continuous Spectrum of 430-780nm Used in the Classroom on Myopia Prevention Among School-Aged Children: A Cluster Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Myopia is a common condition that primarily arises in childhood and remains the most important cause of vision loss for children. Irreversible vision-threatening ocular complications such as posterior staphyloma, myopic maculopathy, and glaucoma may occur with a dramatically high risk once myopia progresses to high myopia. Considering the striking rapid increases in the prevalence of myopia and the premature age of myopia onset, myopia prevention is of extreme urgency and presents several challenges.
It has been proven with solid evidence that outdoor times has effects on myopia prevention, which may be attributed to outdoor light exposure. However, it is difficult to meet the required outdoor times (i.e., at least 2 hours/day) for school-aged children under such educational pressure, especially in China. The differences between the light outdoors and indoors in terms of the light spectrum provide some insights into research to find the alternative. The growth rate of the vitreous cavity in juvenile and adult tree shrews grown under red light with a wavelength of 628±10 nm was significantly slower than those grown under the normal fluorescent lighting group, and red light could induce a hyperopic shift in juvenile tree shrews, thus slowing down the development of myopia. Another experiment has also shown that the use of full-spectrum LED covering a continuous spectrum of 400-775 nm accelerated the recovery from form-deprivation myopia in chickens, and it is hypothesized that full-spectrum lighting may affect the choroid-scleral remodeling pathway, which is thought to be associated with myopia control.
The purpose of this study is to evaluate the effects of LEDs covering a continuous spectrum of 430-780 nm for lighting in the classroom (intervention arm) among students in Grades 2 and 3 compared with regular LEDs with a spectrum of 430-630 nm (control arm). Cluster randomization by class was chosen, and all classes in the same school and grade were equally and randomly assigned to the intervention or control arm, with follow-ups at 1- and 2-year. Vision acuity, ocular biometry, cycloplegic refraction, slit-lamp examinations, optical coherence tomography, optical coherence tomography angiography, and questionnaires will be performed at baseline and during the follow-up.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Zhongshan Ophthalmic Center, Sun Yat-sen University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All the students in Grades 2 and 3 from the 8 schools participated in a myopia surveillance program in Zengcheng District, Guangzhou, China.
- Provision of consent and able to participate in all required activities of the study.
Exclusion Criteria:
- Schools without Grade 2 or Grade 3.
- Schools that only had one class in either grade.
- Children who refused to accept cycloplegia and/or other examinations.
- Children with ocular abnormalities and/or previous history of ocular surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Regular LEDs
Students will accept regular LEDs with a spectrum of 430-630 nm for lighting in the classroom.
|
|
|
Experimental: Novel LEDs
Students will accept novel LEDs with a spectrum of 430-780 nm for lighting in the classroom.
|
LEDs with a continuous spectrum of 430-780 nm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cumulative incidence of myopia.
Time Frame: 2 years
|
Myopia is defined as a cycloplegic spherical equivalent refraction (SER) of at least -0.5 D. Incident myopia was defined as myopia detected in children who did not have myopia at baseline.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in SER (D).
Time Frame: 2 years
|
Change in cycloplegic SER (D) is characterized as the difference between the designed follow-up visit and baseline value.
Refraction is performed with an autorefractor following full cycloplegia.
The SER is calculated as the spherical power (D) plus half of the cylindrical power (D).
|
2 years
|
|
Change in axial length (AL, mm)
Time Frame: 2 years
|
AL change (mm) is characterized as the difference between the designed follow-up visit and baseline value.
The IOLMaster is used to measure AL (mm).
|
2 years
|
|
Satisfaction with classroom lighting
Time Frame: 2 years
|
Subjects are asked to complete a questionnaire to evaluate their satisfaction with classroom lighting during the study period.
|
2 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in corneal curvature (mm)
Time Frame: 2 years
|
Corneal curvature change (mm) is characterized as the difference between the designed follow-up visit and baseline value.
The IOLMaster is used to measure corneal curvature (mm).
|
2 years
|
|
Change in anterior chamber depth (mm)
Time Frame: 2 years
|
Anterior chamber depth change (mm) is characterized as the difference between the designed follow-up visit and baseline value.
The IOLMaster is used to measure anterior chamber depth (mm).
|
2 years
|
|
Change in lens thickness (mm)
Time Frame: 2 years
|
Lens thickness change (mm) is characterized as the difference between the designed follow-up visit and baseline value.
The IOLMaster is used to measure lens thickness (mm).
|
2 years
|
|
Change in choroidal thickness (μm)
Time Frame: 2 years
|
Choroidal thickness change (μm) is characterized as the difference between the designed follow-up visit and baseline value.
Optical coherence tomography is used to measure choroidal thickness.
|
2 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022KYPJ192
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eye Diseases
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
The University of New South WalesUniversity of MelbourneRecruitingDry Eye Disease (DED)Australia
-
Universiti Sains MalaysiaNot yet recruitingDry Eye Disease (DED) | Dry Eye Symptoms | Dry Eye Syndrome (DES)Malaysia
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
The General Authority for Teaching Hospitals and...Recruiting
-
Dompé Farmaceutici S.p.ACompletedDry Eye DiseaseUnited States, Italy
-
Neuro-Ophthalmology of TexasHarrow IncRecruiting
-
Vision Innovation Centers of Pennsylvania, LLC...Nordic Pharma, USARecruiting
-
Demaod LtdNot yet recruitingDry Eye | Dry Eye Syndromes
Clinical Trials on Novel LEDs
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Coordenação de Aperfeiçoamento... and other collaboratorsCompleted
-
VA Office of Research and DevelopmentWithdrawnTraumatic Brain Injury (TBI) | Post-traumatic Stress Disorder (PTSD)United States
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
Johns Hopkins UniversityThe Thomas Wilson Sanitarium for Children of Baltimore CityWithdrawnPreterm Birth | Neurodevelopmental Disorders
-
University of VermontHealthy Design, LLCCompleted
-
Hollister IncorporatedCompleted
-
The Mediterranean Institute for Transplantation...Not yet recruitingStress | Pancreatic Cancer | Anxiety | Pancreatic Cystic LesionsItaly
-
University of Massachusetts, WorcesterBrown UniversityCompletedCommunication | Ventilation Therapy; ComplicationsUnited States
-
University of AlbertaAlberta Innovates Health Solutions; Cosm MedicalRecruitingPelvic Organ Prolapse (POP)Canada